Angiodynamic Inc

AngioDynamics is a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients. The company operates through two segments: Med Tech, which includes the Auryon peripheral atherectomy platform, a thrombus management platform led by the AlphaVac and AngioVac mechanical thrombectomy systems, and the NanoKnife irreversible electroporation (IRE) platform for cancer treatment; and Med Device, which encompasses a broader portfolio of vascular access and other medical devices. AngioDynamics is undergoing a strategic transformation toward its higher-growth, higher-margin Med Tech platforms, which now represent approximately 47% of total revenue. The company's products serve interventional cardiologists, interventional radiologists, vascular surgeons, and urologic oncologists in the treatment of peripheral artery disease, pulmonary embolism, deep vein thrombosis, infective endocarditis, and prostate and liver cancers. The company maintains a debt-free balance sheet and is actively advancing clinical evidence through multiple FDA IDE-approved studies across its portfolio. Updated Jul 14, 2026